Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Bristol Myers Squibb
Bristol Myers Squibb
Envisagenics Announces Research Collaboration with Bristol Myers Squibb
BioSpace
Tue, 11/29/22 - 10:40 am
Envisagenics
artificial intelligence
Bristol Myers Squibb
R&D
Lyvgen and BMS partner for Phase II lung cancer antibody trial
Clinical Trials Arena
Mon, 11/28/22 - 10:18 am
Lyvgen
Bristol Myers Squibb
clinical trials
LVGN7409
non-small cell lung cancer
'Monopoly' allowed Bristol Myers and generics makers to 'steal' from Revlimid purchasers, lawsuit says
Fierce Pharma
Wed, 11/23/22 - 07:33 am
Bristol Myers Squibb
Celgene
Revlimid
patents
generics
Bristol Myers Squibb Threatens New Rules Will Hinder Drug Production
Motley Fool
Mon, 11/21/22 - 09:55 am
Bristol Myers Squibb
drug development
Inflation Reduction Act
Gilead dodges Supreme Court review—and a $1.2B fine—in CAR-T patent feud with Bristol Myers
Fierce Pharma
Mon, 11/7/22 - 05:48 pm
Gilead Sciences
Kite Pharma
Bristol Myers Squibb
cell therapy
legal
CAR-T
Yescarta
Nimbus hopes to best Bristol’s Sotyktu
EP Vantage
Fri, 11/4/22 - 10:15 am
Bristol Myers Squibb
Sotyktu
Nimbus
NDI-034858
psoriasis
With positive trial results, Bristol Myers looks to widen use of blood disease drug
BioPharma Dive
Mon, 10/31/22 - 04:13 pm
Bristol Myers Squibb
Reblozyl
myelodysplastic syndrome
Even as Revlimid's star fades, Bristol Myers' core offerings have reached a 'critical mass,' CEO says
Fierce Pharma
Thu, 10/27/22 - 11:04 am
Bristol Myers Squibb
generics
Revlimid
Abecma
Breyanzi
Pharma CEOs
Giovanni Caforio
MS Drug Advances from Merck, BMS and More Showcased at ECTRIMS Conference
BioSpace
Wed, 10/26/22 - 06:51 pm
Merck
Biogen
Bristol Myers Squibb
MS
multiple sclerosis
ECTRIMS
Bristol Myers Squibb Reports Third Quarter Financial Results for 2022
BioSpace
Wed, 10/26/22 - 10:18 am
Bristol Myers Squibb
earnings
Bristol Myers spells out Opdivo win in melanoma — how does it stack up against Keytruda?
Endpoints
Thu, 10/20/22 - 10:41 am
Bristol Myers Squibb
Opdivo
melanoma
Merck
Keytruda
Few safe havens surface in another down quarter for biopharma
EP Vantage
Fri, 10/14/22 - 10:03 am
biopharma stocks
COVID-19
Eli Lilly
Bristol Myers Squibb
Merck
Daiichi Sankyo
Vertex Pharmaceuticals
Takeda
Neurocrine
Sarepta Therapeutics
Orion
Pfizer
GSK
Roche
Moderna Therapeutics
BeiGene
BioNTech
Novavax
CureVac
BMS-backed Immatics' cell therapy shows early promise in small data set, prompting $110M offering
Fierce Biotech
Tue, 10/11/22 - 10:04 am
Bristol Myers Squibb
Immatics
cell therapy
clinical trials
solid tumors
BioSpace Layoff Tracker 2022: Cyclerion, OncoSec Implement Restructuring Initiatives
BioSpace
Fri, 10/7/22 - 10:45 am
layoffs
Cyclerion
OncoSec
Exicure
AbbVie
Bristol Myers Squibb
Palisade Bio
ObsEva
Rubius Therapeutics
Novartis
Finch Therapeutics
'There are no rules': BMS enters lawless land of molecular degraders with $550M SyntheX deal
Fierce Biotech
Tue, 10/4/22 - 11:04 am
Bristol Myers Squibb
SyntheX
molecular glue
molecular degraders
biobucks
Q3 2022: Layoffs Continue, Alzheimer’s Soars and Accelerated Approvals Fall
BioSpace
Mon, 10/3/22 - 11:33 pm
layoffs
Vesalius Therapeutics
AbbVie
Bristol Myers Squibb
Palisade Bio
IBV
Zymergen
BMS was first but startup Sudo Bio aims to be best at blocking key autoimmune target
MedCity News
Sun, 10/2/22 - 07:38 pm
Sudo Bioscience
TYK2 inhibitors
autoimmune disease
funding
Bristol Myers Squibb
BMS and ConcertAI launch digital trial solution for oncology
Clinical Trials Arena
Fri, 09/30/22 - 10:54 am
Bristol Myers Squibb
ConcertAI
clinical trials
oncology
hematology
urology
Novo Nordisk, Gilead, BMS and AstraZeneca will feel the most pain from Biden's pricing bill: analysts
Fierce Pharma
Mon, 09/26/22 - 11:25 pm
Inflation Reduction Act
Joe Biden
Novo Nordisk
Gilead Sciences
Bristol Myers Squibb
AstraZeneca
drug pricing
AbbVie and BMS slash 360 jobs in California, the latest in a streak of biopharma layoffs
Fierce Pharma
Sun, 09/18/22 - 10:45 pm
AbbVie
Bristol Myers Squibb
layoffs
California
Pages
« first
‹ previous
…
5
6
7
8
9
10
11
12
13
…
next ›
last »